-
The Goldman Sachs Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $32.00
ソース: Buzz FX / 03 3 2025 10:16:16 America/New_York
The Goldman Sachs Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $32.00 Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Apellis Pharmaceuticals ( NASDAQ:APLS - Get Free Report ) had its target price low
Read more...